BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Horn H, Böhme B, Dietrich L, Koch M. Endocannabinoids in Body Weight Control. Pharmaceuticals (Basel) 2018;11:E55. [PMID: 29849009 DOI: 10.3390/ph11020055] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Xiao H, Kang S. The Role of the Gut Microbiome in Energy Balance With a Focus on the Gut-Adipose Tissue Axis. Front Genet 2020;11:297. [PMID: 32318095 DOI: 10.3389/fgene.2020.00297] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
2 Tutunchi H, Saghafi-Asl M, Ostadrahimi A. A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-α, on the management and prevention of obesity. Clin Exp Pharmacol Physiol 2020;47:543-52. [PMID: 31868943 DOI: 10.1111/1440-1681.13238] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
3 Murphy T, Le Foll B. Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs. Biomolecules 2020;10:E855. [PMID: 32512776 DOI: 10.3390/biom10060855] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
4 Gómez-Ambrosi J. The Endocannabinoid System, an Underexploited and Promising Niche for the Pharmacological Treatment of Obesity and Metabolic Diseases. Nutrients 2022;14:421. [PMID: 35276776 DOI: 10.3390/nu14030421] [Reference Citation Analysis]
5 Johnston JR, Freeman KG, Edwards GL. Activity in nodose ganglia neurons after treatment with CP 55,940 and cholecystokinin. Physiol Rep 2018;6:e13927. [PMID: 30512249 DOI: 10.14814/phy2.13927] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Miralpeix C, Fosch A, Casas J, Baena M, Herrero L, Serra D, Rodríguez-Rodríguez R, Casals N. Hypothalamic endocannabinoids inversely correlate with the development of diet-induced obesity in male and female mice. J Lipid Res 2019;60:1260-9. [PMID: 31138606 DOI: 10.1194/jlr.M092742] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Abolghasemi A, Manca C, Iannotti FA, Shen M, Leblanc N, Lacroix S, Martin C, Flamand N, Di Marzo V, Silvestri C. Assessment of the Effects of Dietary Vitamin D Levels on Olanzapine-Induced Metabolic Side Effects: Focus on the Endocannabinoidome-Gut Microbiome Axis. Int J Mol Sci 2021;22:12361. [PMID: 34830242 DOI: 10.3390/ijms222212361] [Reference Citation Analysis]
8 Bonini SA, Premoli M, Tambaro S, Kumar A, Maccarinelli G, Memo M, Mastinu A. Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. J Ethnopharmacol 2018;227:300-15. [PMID: 30205181 DOI: 10.1016/j.jep.2018.09.004] [Cited by in Crossref: 145] [Cited by in F6Publishing: 120] [Article Influence: 36.3] [Reference Citation Analysis]
9 Komarnytsky S, Rathinasabapathy T, Wagner C, Metzger B, Carlisle C, Panda C, Le Brun-Blashka S, Troup JP, Varadharaj S. Endocannabinoid System and Its Regulation by Polyunsaturated Fatty Acids and Full Spectrum Hemp Oils. Int J Mol Sci 2021;22:5479. [PMID: 34067450 DOI: 10.3390/ijms22115479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 O'Sullivan SE, Yates AS, Porter RK. The Peripheral Cannabinoid Receptor Type 1 (CB1) as a Molecular Target for Modulating Body Weight in Man. Molecules 2021;26:6178. [PMID: 34684760 DOI: 10.3390/molecules26206178] [Reference Citation Analysis]
11 Higgins MJ. The Renaissance of the First Century and the Origin of Standard Late Greek. Traditio 1945;3:49-100. [DOI: 10.1017/s036215290001686x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
12 Kessler C. Pathophysiology of Obesity. Nurs Clin North Am 2021;56:465-78. [PMID: 34749888 DOI: 10.1016/j.cnur.2021.08.001] [Reference Citation Analysis]
13 Augustin SM, Lovinger DM. Synaptic changes induced by cannabinoid drugs and cannabis use disorder. Neurobiology of Disease 2022;167:105670. [DOI: 10.1016/j.nbd.2022.105670] [Reference Citation Analysis]
14 Zuccarini G, D'Atri I, Cottone E, Mackie K, Shainer I, Gothilf Y, Provero P, Bovolin P, Merlo GR. Interference with the Cannabinoid Receptor CB1R Results in Miswiring of GnRH3 and AgRP1 Axons in Zebrafish Embryos. Int J Mol Sci 2019;21:E168. [PMID: 31881740 DOI: 10.3390/ijms21010168] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
15 Gorelick J, Assa-glazer T, Zandani G, Altberg A, Sela N, Nyska A, Madar Z. THC and CBD affect metabolic syndrome parameters including microbiome in mice fed high fat-cholesterol diet. J Cannabis Res 2022;4. [DOI: 10.1186/s42238-022-00137-w] [Reference Citation Analysis]
16 Müller TD, Blüher M, Tschöp MH, DiMarchi RD. Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov 2021. [PMID: 34815532 DOI: 10.1038/s41573-021-00337-8] [Reference Citation Analysis]
17 Fonseca L, Castillo V, Aguirre C, Silva P, Ronco AM, Llanos M. Stress during Lactation Induces Insulin Resistance Associated with an Increase in Type 1 Cannabinoid Receptors in Liver and Adipose Tissue. J Nutr Metab 2019;2019:2806519. [PMID: 30800481 DOI: 10.1155/2019/2806519] [Reference Citation Analysis]
18 Bonaccorso S, Ricciardi A, Zangani C, Chiappini S, Schifano F. Cannabidiol (CBD) use in psychiatric disorders: A systematic review. Neurotoxicology 2019;74:282-98. [PMID: 31412258 DOI: 10.1016/j.neuro.2019.08.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 11.0] [Reference Citation Analysis]
19 Coccurello R, Marrone MC, Maccarrone M. The Endocannabinoids-Microbiota Partnership in Gut-Brain Axis Homeostasis: Implications for Autism Spectrum Disorders. Front Pharmacol 2022;13:869606. [DOI: 10.3389/fphar.2022.869606] [Reference Citation Analysis]
20 Müller GA, Herling AW, Wied S, Müller TD. CB1 Receptor-Dependent and Independent Induction of Lipolysis in Primary Rat Adipocytes by the Inverse Agonist Rimonabant (SR141716A). Molecules 2020;25:E896. [PMID: 32085406 DOI: 10.3390/molecules25040896] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]